While it is complicated to identify the modifying gene/s that interact with apoA-IV in these two different background mice, a thorough understanding of the modifying genes using advanced technology, e.g., RNA sequence, will be invaluable to human biology and the opportunity to develop drugs for human obesity and diabetes. The gene discussed is APOA4; the disease is diabetes mellitus.